c terminal carbohydrate recognition domain gal 3c (Galectin Therapeutics)
Structured Review
C Terminal Carbohydrate Recognition Domain Gal 3c, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recognition/pm42101653-42-23-0
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2. Article Snippet: |
